Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Other 1

Conditions

Breast Neoplasms 2Vitamin D Deficiency 1Triple Negative Breast Neoplasms 1Obesity 1Bone Metabolism Biomarkers 1

Interventions

Specimen Handling 274Magnetic Resonance Spectroscopy 226pembrolizumab 225Carboplatin 178Biopsy 165Cisplatin 162Nivolumab 157Cyclophosphamide 146Paclitaxel 124Radiotherapy 123Gemcitabine 114Bevacizumab 92durvalumab 91Dexamethasone 87Rituximab 80Oxaliplatin 80venetoclax 73atezolizumab 70Doxorubicin 70Fluorouracil 69Docetaxel 69Capecitabine 68Etoposide 66Radiosurgery 65Ipilimumab 63Radiation 60Prednisone 60Cytarabine 60Lenalidomide 59fludarabine 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Cholecalciferol × 90 days × Clear all
NCT01472445 2026-04-23

Vitamin D and Breast Cancer: Does Weight Make a Difference?

Stanford University

Phase 2 Terminated
41 enrolled 16 charts
BreastOther

Breast Neoplasms, Obesity

NCT04677816 2026-04-14

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Wake Forest University Health Sciences

Phase 2 Recruiting
50 enrolled
Breast

Vitamin D Deficiency, Triple Negative Breast Neoplasms

NCT01419730 2026-04-07

Vitamin D and Physical Activity on Bone Health

University of Rochester

Phase 2 Active not recruiting
191 enrolled

Bone Metabolism Biomarkers

NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡